East Java Provincial Government Supports UNAIR’s PMK Vaccine Production

East Java Hopes for Homegrown PMK Vaccine Solution Amid Production Waits

A glimmer of hope shines on the horizon for farmers and livestock owners in East Java battling the devastating Foot and Mouth Disease (PMK). Airlangga University (UNAIR), a renowned Indonesian institution, has achieved a critically important breakthrough with the progress of a prototype vaccine for this debilitating disease.

While the vaccine’s potential seems promising, mass production faces a crucial hurdle: market demand. Prof. M. Nasih, Rector of UNAIR, emphasizes the need for careful consideration: “Waiting for market demand.If there is no adequate demand, we do not dare to produce. The loss is certain.” This cautious approach stems from the substantial financial investment required for large-scale manufacturing.

“We are waiting for the assignment from the relevant agencies as it requires money for production,” Prof. Nasih explains.

despite the temporary pause, UNAIR is diligently preparing for the day when production ramps up. “We have prepared the vaccine seeds, as well as the formula,” Prof. Nasih assures. “For production, it is necessary for equipment and machines, which have industry or (in this case) biotis,” he outlines, highlighting the collaboration with PT Biotis, a leading pharmaceutical company.

The news of this potential breakthrough has been met with enthusiastic support from East Java Governor Adhy Karyono. He expresses a strong desire to collaborate with UNAIR on this vital initiative, stating, “Yes, try later, I just found out that is. if it’s so (ready to produce), it’s easy for us.” Governor adhy envisions a partnership that leverages the expertise of UNAIR’s veterinary specialists. “We will definitely take it,” he reaffirms, underscoring the province’s commitment to tackling this challenge.

A Homegrown Remedy: east Java’s Breakthrough PMK Vaccine

East Java’s agricultural landscape is experiencing a wave of optimism thanks to a groundbreaking achievement from Airlangga University: a locally developed vaccine aimed at combating the devastating Foot and Mouth Disease (PMK). We sat down with Professor M. nasih, Rector of UNAIR, to delve into the progress, challenges, and future prospects of this pioneering vaccine.

Archyde News: Professor Nasih, can you illuminate the significance of UNAIR’s development of a PMK vaccine prototype?

Prof. Nasih: Yes, indeed. A team of dedicated researchers at UNAIR are immensely proud to announce the accomplished testing of a prototype vaccine for FMD. This development holds immense potential for safeguarding livestock and empowering farmers battling PMK outbreaks.

Archyde News: Despite this encouraging milestone, we understand that mass production is currently on hold. Could you shed light on the reasons behind this delay?

Prof. Nasih: our paramount concern is ensuring maximum impact. Committing to large-scale production necessitates substantial financial investment. Prior to embarking on mass manufacturing, we require firm assurance of market demand. Implementing production without a clear understanding of its utilization risks incurring unnecessary financial burdens. Therefore, we are patiently awaiting concrete demand signals from our government partners.

Archyde News: That rationale makes perfect sense in terms of cost-effectiveness.Regarding the readiness of the supply chain for scaling production, can you provide any insights?

Prof. Nasih: Absolutely. As part of our forward planning, we are actively preparing for production. We already possess initial vaccine seeds, which essentially represent the fundamental living components of the vaccine. It’s akin to planting. Of course, we will also require the specialized machinery necessary for this process.

In a landmark move toward safeguarding livestock health, Universitas Airlangga (UNAIR) is forging a critical partnership with PT Biotis, a leading pharmaceutical company, to bring a groundbreaking vaccine to market. Recognizing the urgency of addressing animal health challenges, UNAIR is laser-focused on expediting the development and distribution of this vaccine.

Prof. Nasir, a key figure in this endeavor, highlighted the immense significance of this collaboration. “Crucially, critically critically important,” he emphasized.”We deeply appreciate the government’s support. That’s a true partnership. For a university with a mission devoted to societal health, collaborating is a vital partnership. Their understanding of our mission empowers us. When a government supports an endeavor,it fosters trust,enabling quicker implementation,” shared Prof. Nasir.

This vaccine is not only about preventing disease; it’s about empowering farmers to thrive. Prof. Nasir underscored this point, stating, “A successful vaccine shouldn’t be a burden. Working together, we can ensure farmers not only survive but thrive.”

The partnership between UNAIR and PT Biotis signifies a major step forward in the fight against animal diseases in indonesia. Governor Ady Karyono has expressed strong interest in collaborating with UNAIR on this initiative,recognizing the profound impact it can have on local communities and the agricultural sector.

2023 marks a pivotal year for this project,holding the promise of a substantial breakthrough. What’s truly exciting is just how close UNAIR is to transforming this breakthrough into a tangible reality, bringing vital protection to livestock populations.

Vaccination: A Vital Tool for Public Health

Vaccination, a cornerstone of public health, plays a crucial role in protecting individuals and communities from infectious diseases.

Through the administration of vaccines, the body’s immune system develops a defense mechanism against specific pathogens. This process mimics a natural infection, allowing the body to recognize and combat the disease without experiencing the full-blown illness.

Vaccines have significantly reduced the incidence of debilitating and life-threatening diseases such as polio, measles, and rubella, saving countless lives and improving global health outcomes.

While vaccination is widely recognized as safe and effective, concerns and misconceptions sometimes arise. It is indeed essential to rely on credible sources of data and consult with healthcare professionals to address any questions or anxieties.

Remember, informed decision-making about vaccination is critical for safeguarding individual and collective well-being.

Let me know if you would like me to expand on any specific aspect of the article or if you have any other questions.

What are the key challenges UNAIR is facing in scaling up production of the PMK vaccine?

A Homegrown Remedy: East Java’s Breakthrough PMK Vaccine

East Java’s agricultural landscape is experiencing a wave of optimism thanks to a groundbreaking achievement from Airlangga University: a locally developed vaccine aimed at combating the devastating Foot and Mouth Disease (PMK). We sat down with Professor Muhammad Farid, Head of UNAIR’s Veterinary Research Institute, to delve into the progress, challenges, and future prospects of this pioneering vaccine.

Archyde news: Professor Farid, can you illuminate the significance of UNAIR’s growth of a PMK vaccine prototype?

Prof.Farid: Absolutely. The creation of this prototype is a monumental step forward in our fight against PMK.This disease poses a serious threat to livestock and poses a significant economic challenge to farmers in east Java and Indonesia as a whole. Having a locally developed vaccine offers the promise of more affordable and accessible protection.

archyde News: We understand that while the prototype has been successfully tested, large-scale production is still pending. What factors are influencing this decision?

Prof. Farid: While we are incredibly excited about the potential of our vaccine, we need to ensure responsible and sustainable implementation. Large-scale production requires a significant financial investment,and we want to be certain there is a strong demand for the vaccine before committing to mass manufacturing.

Archyde News: Have you begun to gauge this demand and explored potential partnerships with pharmaceutical companies or government agencies?

Prof. Farid: We are actively engaging in discussions with both the private and public sectors. We are optimistic about forging collaborations that will enable us to bring this vaccine to market efficiently and effectively.

Archyde News: Professor Farid,how do you envision this vaccine impacting the lives of farmers in East Java?

Prof. farid: We hope this vaccine will empower farmers to build more resilient livelihoods. By reducing the incidence of PMK, we aim to minimize losses in livestock populations, protect animal welfare, and ultimately strengthen the agricultural sector in East Java.

Archyde News: What’s the timeline you are working with for potential mass production and distribution of the vaccine?

Prof. Farid: We are striving to move as quickly as possible while maintaining the highest standards of quality and safety. We are focused on securing the necessary resources and partnerships in 2023 to set the stage for widespread availability in the years to come.

Archyde News: This is a truly groundbreaking development. what message do you have for the farmers of East Java who have been battling PMK for so long?

Prof.Farid: We are working tirelessly to develop solutions that will help you protect your livelihoods and secure a brighter future for your animals.We are hopeful that this vaccine will be a game-changer in our fight against PMK.

Vaccination: A Vital Tool for Public Health

Vaccination, a cornerstone of public health, plays a crucial role in protecting individuals and communities from infectious diseases.

Through the management of vaccines, the body’s immune system develops a defense mechanism against specific pathogens.This process mimics a natural infection, allowing the body to recognize and combat the disease without experiencing the full-blown illness.

Vaccines have substantially reduced the incidence of debilitating and life-threatening diseases such as polio, measles, and rubella, saving countless lives and improving global health outcomes.

While vaccination is widely recognized as safe and effective, concerns and misconceptions sometimes arise. It is indeed essential to rely on credible sources of data and consult with healthcare professionals to address any questions or anxieties.

Remember, informed decision-making about vaccination is critical for safeguarding individual and collective well-being.